BackSecond Sight Medical Products Overview

Second Sight Medical Products Receivables

Latest receivables for EYES: $12K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$12000.00

Peer average

Loading

Second Sight Medical Products Receivables History

Loading

Second Sight Medical Products vs. peers: Receivables Comparison

Loading

Second Sight Medical Products Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Second Sight Medical Products (EYES) FAQ

Second Sight Medical Products (EYES) currently reports a receivables of $12K as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Second Sight Medical Products's receivables history and peer comparisons.

Second Sight Medical Products's receivables changed from $0 to $12K (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Second Sight Medical Products reported $12K in receivables as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $12K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Second Sight Medical Products, and consider following EYES for alerts when major investors trade the stock.

Second Sight Medical Products is classified in the Healthcare sector. On receivables, it currently shows $12K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EYES with unrelated industries.